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Abstract
We deduce a model for glioma invasion making use of DTI data and accounting for the dy-
namics of brain tissue being actively degraded by tumor cells via excessive acidity production,
but also according to the local orientation of tissue fibers. Our approach has a multiscale charac-
ter: we start with a microscopic description of single cell dynamics including biochemical and/or
biophysical effects of the tumor microenvironment, translated on the one hand into cell stress
and corresponding forces and on the other hand into receptor binding dynamics; these lead on
the mesoscopic level to kinetic equations involving transport terms w.r.t. all kinetic variables
and eventually, by appropriate upscaling, to a macroscopic reaction-diffusion equation for glioma
density with multiple taxis, coupled to (integro-)differential equations characterizing the evolu-
tion of acidity and macro- and mesoscopic tissue. Our approach also allows for a switch between
fast and slower moving regimes, according to the local tissue anisotropy. We perform numerical
simulations to investigate the behavior of solutions w.r.t. various scenarios of tissue dynamics and
the dominance of each of the tactic terms, also suggesting how the model can be used to perform
a numerical necrosis-based tumor grading or support radiotherapy planning by dose painting. We
also provide a discussion about alternative ways of including cell level environmental influences
in such multiscale modeling approach, ultimately leading in the macroscopic limit to (multiple)
taxis.
1 Introduction
Glioma is a common type of primary, fast growing brain tumor with a poor prognosis, the
median survival time with the most frequent (and most aggressive) form called glioblastome
multiforme amounting at 60 weeks, in spite of modern treatment involving resection, radio-, and
chemotherapy (see e.g., [91] and references therein). An exhaustive removal of the tumor is in
general impossible, due to the rapid advancement of glioma cells through their cycle and to the
diffuse tumor infiltration. This leads to serious clinical challenges and to rather modest treatment
outcomes. The correct assessment of tumor margins and of the related GTV, CTV, and PTV1
is therefore of utmost importance. Noninvasive medical imaging techniques like MRI and CT
are valuable diagnostic tools, however they only provide a macroscopic classification of neoplastic
regions and the surounding oedema, without being able to evaluate the actual tumor extent which
is heavily influenced by the biological, mechanical, and chemical processes on single cell and
subcellular levels. Moreover, every patient has a different brain structure and there is abundant
evidence that glioma follow the white matter tracts made up of myelinated axon bundles [32,33].
Therefore, the personalized prediction of the tumor burden is necessary for an enhanced therapy
planning and mathematical models are called upon to provide such information via numerical
simulations, thereby relying on medical data, of which diffusion tensor imaging (DTI) is quite
common [80]. It measures the spatial diffusion of water molecules by MRI per volume element
(voxel). The information obtained in this way can be expressed in the form of a diffusion tensor
containing the full (apparent) diffusion information along six directions. One way of visualizing
1GTV=gross tumor volume; CTV= clinical target volume; PTV=planning target volume
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diffusion tensors is by the so-called fractional anisotropy index FA which is a measure for the
local tissue alignment and can directly be obtained from DTI data; it is a scalar value between
zero and one, calculated by using the eigenvalues of the apparent diffusion tensor. A value close
to one means high anisotropy, i.e., a strong preference for a specific direction, whereas a very
small value corresponds to the nearly isotropic case. For more details we refer e.g., to [10], see
also [25]. For more about DTI and its visualization approaches along with advantages, drawbacks
and extensions we refer e.g., to [2, 24,44].
Several approaches to modeling glioma invasion have been considered so far; they range from
discrete formulations [36,45,46] over hybrid settings [31,82,93] combining decriptions of individual
cells moving on a lattice with PDEs describing the evolution of some stimulus (e.g., a chemoat-
tractant) and up to pure continuum models coupling several types of differential equations. The
latter category comprises in turn several classes of models, according to the scales taken into
account and to the type of PDEs employed. Pure macroscopic models using reaction-diffusion
equations (possibly with space- and time-dependent diffusion coefficients, or accounting for the
interaction with the surrounding tissue by letting the diffusion coefficient be proportional to the
water diffusion tensor assessed by DTI) have been introduced e.g., in [13, 43, 53, 85] to charac-
terize the evolution of glioma density; in [21] some biomechanical effects have been included as
well. While these models impose the precise form of the equations and their coefficients, other
approaches [39, 72] deduce them by using a scaling argument from a mesoscopic setting relying
on kinetic transport equations for the glioma density function depending -supplementary to time
and position- also on the cell velocities. These models have been further extended in [25–27,41] to
take into account subcellular level effects on the mesoscopic and ultimately macroscopic behavior
of the tumor. Concretely, these multiscale settings included on the microscopic level receptor
binding to tissue fibers, which was related to the mesoscale by way of an additional transport
term and by the turning rate. Appropriate scalings then led to the macroscale dynamics, whose
deduced coefficients are still carrying subcellular level information. In [68] different types of scal-
ing have been considered for this modeling approach, and a well-posedness result was provided
for a model also involving the time-space evolution of tissue. A more general analytical result in
less regular function spaces for a complex micro-meso-macroscale model involving both chemo-
and haptotaxis introduced on the mesolevel has been proved in [61].
Here we propose a multiscale model starting from a kinetic transport equation formulation and
accounting, too, for receptor binding dynamics. Unlike in [25–27,41] where the space-dependent
tissue was given by DTI data at a fixed time point and the glioma cells were migrating on this
brain structure, in the current model the tissue is allowed to evolve in time as well and the glioma
cells degrade it according to their respective orientation to the tissue fibers, similarly to the way
introduced in [38] and readdressed in [61,68]. Moreover, in this work we also include a character-
ization of velocity changes via a transport term involving derivatives with respect to the velocity
variable, hence allowing for external forces to act on the cells. Specifically, these external actions
are decisively influenced by the spatial gradients of tissue fibers in the tumor surroundings and
by the bias induced through the acidity gradient. Reference [19] considered a similar approach
accounting for a given chemotactic force acting on the cells and being proportional to the concen-
tration gradient of some non-evolving chemoattractant. Here we pay more detailed attention to
the influence of time- and space-dependent acidity and tissue on the cell migration, proliferation,
and depletion, thereby also looking into the effect of tissue fiber orientation, hence dealing with
both macroscopic and mesoscopic tissue evolution. By formal upscaling we then obtain a system
of ordinary and partial (integro-)differential equations with (myopic) diffusion, multiple taxis,
and nonlinear source terms, which couples macroscopic dynamics of tumor cells, necrotic matter,
acidity, and normal tissue with that of mesoscopic tissue. The rest of the paper is organized as
follows: in Section 2 we set up the micro- and mesoscopic descriptions of (sub)cellular glioma
dynamics in the kinetic theory of active particles (KTAP) framework developed e.g., in [6, 7]
and also provide descriptions of the other involved model variables: tissue, necrotic matter, and
acidity. Section 3 is dedicated to deducing effective equations for the macroscopic glioma density
influenced by tissue and acidity dynamics. Formal parabolic and hyporbolic upscalings are per-
formed and a low-order moment approximation is deduced for the characterization of mesoscopic
tissue, in order to reduce the complexity of the system. Numerical simulations are conducted
in Section 4 for three different scenarios of increasing complexity, and the obtained results are
compared and commented. Finally, Section 5 provides a discussion of this work’s outcome, model
extensions, and perspectives, along with a review of various ways of multiscale modeling of tactic
cell behavior in the KTAP framework.
2
2 Set up of the micro-meso model
Our modeling approach aims at obtaining a macroscopic description of the tumor cell evolution
in interaction with the underlying tissue. The resulting PDE should carry in its coefficients infor-
mation about relevant processes occuring on the lower levels (subcellular/microscopic, individual
cells/mesoscopic) and should be deduced from mathematical descriptions of the dynamics on the
latter. On the macroscopic scale the two main components of cell motion in a tissue should be
retrieved, namely diffusion and haptotaxis.
We start by introducing some notations for the various variables and functions involved in
this work.
Notation 1
• Mechanical variables: time t ∈ R+, space x ∈ RN , velocity v ∈ V := sSN−1, where SN−1
is the unit sphere in RN , and, as in [25–27, 38, 42], we assume the cell speed s > 0 to be
constant.
• vˆ := v|v| a unitary vector denoting the direction of a vector v ∈ V .
• Q(t, x): macroscopic tissue density.
• Biological (activity) variable y: volume fraction of bound receptors on the cell membrane.
Its dynamics is given by an ODE obtained for y by mass action kinetics of receptor bindings
and detachments (with rates k+ and k−, respectively):
y˙ = k+(R0 − y)Q(t, x)− k−y, y ∈ (0, R0). (2.1)
This represents in our model the subcellular dynamics. Thereby, as in previous works
[49, 68], we assume for simplicity that the total amount of cell membrane receptors R0 is
constant and we rescale y → y/R0, thus obtaining2
y˙ = G(y,Q) := k+(1− y)Q(t, x)− k−y, y ∈ Y := (0, 1) (2.2)
• p(t, x, v, y): density function of tumor cells (mesoscopic tumor cell density). We will also
use p¯(t, x, y) :=
∫
V
p(t, x, v, y)dv.
• ρ(t, x) :=
∫
Y
p¯(t, x, y)dy =
∫
Y
∫
V
p(t, x, v, y)dvdy: macroscopic density of tumor cells.
• q(t, x, θ): directional distribution function of tissue fibers with orientation θ ∈ SN−1, where
SN−1 denotes the unit sphere in RN . Hence
∫
SN−1 q(t, x, θ)dθ = 1.
• Eq(t, x) :=
∫
SN−1 θq(t, x, θ)dθ: mean fiber orientation.
• Vq(t, x) :=
∫
SN−1(θ − Eq(t, x)) ⊗ (θ − Eq(t, x))q(t, x, θ)dθ: variance-covariance matrix for
orientation distribution of tissue fibers.
• h(t, x): concentration of acidity (protons), a genuinely macroscopic quantity.
• n(t, x): density of necrotic tissue (also a macroscopic quantity).
• λ(x, y): cell turning rate.
Next we characterize innovations of cell density function due to changes in velocity and ac-
tivity variable under the influence of the tissue structure. Depending on their nature, these are
incorporated into the model in different ways:
(i) As transport parts of the mesoscopic equation for the cell density function p: a divy term
accounts for the binding of cell receptors to tissue fibers, while a divv term describes biome-
chanical effects, such as cell stress and directionality dictated by the spatial variations in
(mesoscopic) tissue density and macroscopic acidity concentration.
(ii) As a jump process, being modeled as an integral operator L0 on the right-hand side of the
equation. The kernel of that operator will depend as in previous works [25–27,38,42] on the
tissue structure, by way of the fiber directional distribution q(t, x, vˆ), as will be explained
below.
2Observe that the activity variable y belongs to an open set; indeed, y = 0 would mean that no receptors are bound
(which is not possible for cells living in tissue), while y = 1 would correspond to all receptors being occupied (which
actually never happens, as it would impede migration, proliferation, and even cell survival, due to anoikis). For an
actual mathematical justification we refer to [49,61].
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(iii) As a source term describing proliferation/decay and being modeled as another integral oper-
ator P. This can be done for instance similarly to the approach in [26], where the interaction
of cells with the surrounding tissue was considered to be at the onset of cell survival and
mitosis. Here we modify that approach in order to account for the unfavorable effect of
acidity on these processes. The concrete form of the corresponding term P(p,Q, h, ρ) will
be specified later.
Thus, the equation for p takes the following form:
∂tp+ v·∇xp+ ∂y(G(y,Q)p) + αdivv
(
B(v)(∇xq(t, x, vˆ)−∇xh(t, x))p
)
= λ(x, y)L0(p) + P(p,Q, h, ρ), (2.3)
where we used the notation B(v) := |v|2IN − v ⊗ v, and where the transport coefficients are
obtained from the subcellular (microlevel) dynamics 3:
dx
dt
= v;
dv
dt
= αB(v)(∇xq(t, x, vˆ)−∇xh(t, x)); dy
dt
= G(y,Q), (2.4)
the latter equation in (2.4) being just (2.1) and the middle equation characterizing the dynamics
of v influenced by the space gradients of the directional distribution of tissue fibers and of the
acidity. Thereby, the tensor v ⊗ v represents the active cell stress, while −|v|2IN is the isotropic
part. Indeed, concerning cell velocities we are foremost paying attention to the direction of the
vector v and consider that it is mainly influenced by the fiber distribution (and in particular by
its spatial variations), as well as by the acidity gradient. The latter is known to drive the tumor
cells and seems to have a bidirectional effect: Low extracellular pH favorizes both their migration
and proliferation [29,79,86], but acidosis can also inhibit cell proliferation, induce stress response,
and apoptosis, see e.g. [69]. Specifically in glioblastoma multiforme (GBM) it can trigger motion
in the opposite direction of the acidity gradient. Indeed, GBM cells form typical, garland-like
structures called pseudopalisades, which are centered around the highly hypoxic occlusion site of
a capillary [14,89]. The presence of such histological patterns is an indication for poor prognosis
of patient survival [51]. In order not to complicate the exposition too much we will only consider
here the latter situation, with the repellent effect of acidity, hence the motion of glioma cells
being biased towards −∇xh.
The dimensionless parameter α will play an important role, since it incorporates information
from the different scales on which the tumor density, fiber directional distribution or acidity are
correlated. While the tumor has volume dimensions, the path of travel made up of targeting
fibers has a thinner structure close to the flat one. We can assume that the relationship with
acidity is similar in scale. Therefore, the gradients of q and h w.r.t. x contribute with this new
scale parameter α among the agents of this process, which must be, as a consequence, a large
quantity.
Observe that the dynamics of v in (2.4) ensures that d|v|
2
dt , hence the cell speed |v| = s is
constant (in line with the above assumption V = sSN−1), hence only the direction matters.
For the evolution of acidity concentration h we also need to provide an equation; it will take
the form of a reaction-diffusion PDE describing the facts that protons diffuse through the entire
available space with diffusion parameter DH , acidity is produced by cancer cells, and may infer
decay, e.g. through uptake by vasculature or normal cells. We denote by b > 0 the uptake rate
and consider a limited production by cancer cells irrespective of their motility and/or receptor
binding state, with a constant rate a > 0. In (2.5) the constant h0 denotes an acidity threshold
which is critical for non-cancerous matter; the proton buffering is enhanced when that threshold
is exceeded, and it is limited by the availability of normal tissue and cells, which decreases under
hypoxia (as explained later on):
ht = DH∆h+
aρ
1 + ρ
− bQ(h− h0). (2.5)
The turning operator L0 on the right hand side in (2.3) is taken as a relaxation-type operator
describing the velocity-jump discontinuities in the cell density function p due to contact guidance,
3Strictly speaking we understand the ODEs for v and y as being written for tissue q, Q and acidity h, scaled with
their reference quantities (e.g., tissue carrying capacity KQ and acidity threshold h0 introduced below), but for the
sake of simplifying the notation we do not explicitly write those denominators. Same applies to the complementary
solution components involved in the source terms of the forthcoming equations for cell density, acidity, and necrotic
matter.
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that is, these velocity alterations are assumed to be caused by the cells interacting with tissue
fibers and adapting their motion to biochemical (biomechanical, etc.) cues available at sites in
their direct proximity. More precisely, it is given by
L0(p) := p¯(t, x, y)M(t, x, v)− p(t, x, v, y), (2.6)
where M(t, x, v) depends on the fiber directional distribution q:
M(t, x, v) :=
q(t, x, vˆ)
ω
, ω :=
∫
V
q(t, x, vˆ) dv,
thus
∫
V
M(t, x, v) dv = 1. Notice that this corresponds to considering, as in [25–27, 38, 72], a
turning operator of type
L0(p) := −p(t, x, v, y) +
∫
V
K˜(v, v′)p(t, x, v′, y)dv′
with the turning kernel defined by K˜(v, v′) = q(t,x,vˆ)ω , that is, the random migration from any
velocity v′ to a new one v is given by the (normalized) orientational distribution of tissue fibers on
this last velocity v, so through contact guidance. We recall that this turning operator is multiplied
by the cell turning rate λ(x, y). It will play an essential role in our attempt to characterize the
alternation between slow and enhanced migration of tumor cells, which is mainly due to the tissue
anisotropy. To capture this dependence we use the fractional anisotropy index FA mentioned in
Section 1. Henceforth we deal with a turning rate of the form
λ(x, y) =
κy
FA(x) + y
,
which is in agreement with the assumption of reduced turning in highly aligned regions and with
its dependence on the receptor binding state y, the latter with a certain saturation modeled by
the Monod type factor. Thereby, κ is a constant that refers to the maximum turning frequency.
Finally, we introduce the proliferation/decay operator. Similarly to the approach in [26], both
proliferation and decay of tumor cells originate (at least partially) in the interaction of cells with
the surrounding tissue, but here we modify that approach in order to account for the unfavorable
effects of acidity on these processes. Concretely, P(p,Q, h, ρ) is given by
P(p,Q, h, ρ) := µ(ρ, h)
∫
Z
χ(x, z, z′)p(t, x, v, z′)Q(t, x)dz′, (2.7)
where χ(x, z, z′) is a kernel with respect to z and represents the transition from the state z′ to
the state z during a proliferation-favorable glioma-tissue interaction.
For the tissue dynamics we adopt the approach in [38] which was also employed in [49,61,68],
with slight modifications. We look for the evolution of q(t, x, θ), hence want an equation of the
form
∂tq(t, x, θ) = τ(θ, p, q),
with τ satisfying the natural conditions:
τ(·, ·, 0) = 0,
∫
SN−1
τ(θ, ·, ·)dθ = 0, ∀ θ ∈ SN−1.
We thus compare -as in [38]- the fiber orientation θ with the cell direction vˆ, and introduce
the operator:
Π[p](t, x, θ) :=
{
1
ρ(t,x)
∫
Y
∫
V
|θ · vˆ|p(t, x, v, y) dv dy, for undirected tissue
1
ρ(t,x)
∫
Y
∫
V
θ · vˆ p(t, x, v, y) dv dy, for directed tissue, (2.8)
which averages the projection of cell movement direction on the fiber orientation. It models
the fact that cells preferentially degrade fibers which are nearly orthogonal to their movement
direction (for more details see [38]). It holds that 0 ≤ Π[p] ≤ 1 and −1 ≤ Π[p] ≤ 1 for undirected
and for directed tissue, respectively. Thereby, undirected means that the fibers making up the
tissue are symmetrical all along their axes, i.e. there is no ’up’ and ’down’ on such fibers, which
translates into symmetry of the orientational distribution:
q(t, x,−θ) = q(t, x, θ), ∀ θ ∈ SN−1.
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If this is not the case, then the tissue is said to be directed. These tissue properties reflect
on the cell motility: While undirected fibers do not impose any supplementary bias on the
(re)orientation of a cell, in a directed tissue the cells will have a preferred direction of advancement
along the fibers. As DTI data do not provide any information about such directionality, we will
consider in the following both types of tissue, which will lead to two different ways of performing
the transition from the lower scales (micro and meso) to the macroscopic description of tumor
dynamics in interaction with their fibrous and biochemical surroundings.
If we denote by g(t, x, θ) the mesoscopic density of tissue fibers with orientation θ we obtain
for the evolution of this quantity the equation
∂tg(t, x, θ) = rD(h)(Π[p](t, x, θ)− 1)ρ(t, x)g(t, x, θ), (2.9)
where rD is a nonnegative quantity characterizing the efficiency of fiber degradation (e.g., it
can be considered to be proportional to the amount of matrix degrading enzymes4 expressed by
the cells, thus to the acidity h, since MDEs are actually known to be enhanced by an acidic
extracellular pH, see [16,47]). We then consider rD to be a monotonically increasing function of
h with rD(h) = r0(h− h0)+.
It would be important to have information about the directional distribution function q(t, x, θ),
hence we express the latter with respect to the mesoscopic tissue density g(t, x, θ). Following [38],
this relationship takes the form
q(t, x, θ) =
g(t, x, θ)∫
SN−1 g(t, x, θ)dθ
, g 6= 0.
The macroscopic tissue density Q(t, x) represents the volume fraction of tissue fibers, irre-
spective of their orientation, thus we also have the following relationship:
g(t, x, θ) = q(t, x, θ)Q(t, x), t > 0, x ∈ RN , θ ∈ SN−1. (2.10)
Integrating (2.9) w.r.t. θ ∈ SN−1 we get
∂tQ = rD(h)ρQ
(∫
SN−1
Π[p](t, x, θ)q(t, x, θ)dθ − 1
)
= rD(h)ρQ
∫
SN−1
(
Π[p]− 1)q dθ. (2.11)
In the sequel the average of Π[p] w.r.t. the distribution of fiber orientations will be denoted
as in [38] by
A[p](t, x) :=
∫
SN−1
Π[p](t, x, θ)q(t, x, θ)dθ, (2.12)
hence (2.11) becomes
∂tQ = rD(h)ρQ(A[p]− 1). (2.13)
Likewise, we can deduce an equation for the fiber directional distribution function:
∂tq(t, x, θ) = rD(h)ρ(t, x)q(t, x, θ) (Π[p](t, x, θ)−A[p](t, x)) . (2.14)
Eventually, the decay of both tissue and glioma (primarily due to acidity) generates necrotic
tissue, large amounts of which are an indicative of poor survival prognosis [35, 62]. Therefore,
the detection and assessment of necrosis is an important issue in therapy. Here we describe the
dynamics of necrotic tissue density by
∂tn = rD(h)ρQ
∫
SN−1
(1−Π[p](t, x, θ))q(t, x, θ)dθ + F(h, ρ,Q) (2.15)
where F(h, ρ,Q) describes glioma death due to hypoxia and is to be specified later.
Thus, the full model for cell-tissue interactions and response to acidity is given by (2.3), (2.5),
(2.13), (2.14), (2.15), supplemented with appropriate initial and boundary conditions.
As in previous works [25–27, 49] we assume p to be compactly supported in the (v, y)-space.
The initial conditions and the boundary conditions w.r.t. space will be addressed in the following
sections. The wellposedness of this problem (especially in less regular function spaces) is not
trivial and also not the aim of this paper. When the space domain is the whole RN the approach
in [48,49,61] could be used as a starting point in order to address this issue.
4shortly MDEs
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3 Towards population behavior: Upscaling
Our objective is to assess the macroscopic evolution of the tumor cell population interacting
with the brain tissue. As the latter exhibits anisotropy variability, with highly aligned regions
alternating with areas of isotropic fiber distribution, the invasive behavior of glioma cells will be
correspondingly -and locally- dominated by diffusion with or without drift. Therefore, it is desir-
able that our model includes a switch between these two kinds of motion, in the sense that the
influence of drift together with diffusion can be potentiated against pure diffusion. These effects
are built in via the turning rate λ(x, y) given in Section 2 above. Indeed, its dependence on the
(local) fractional anisotropy FA(x) and the amount of receptors bound to their ligands on the
tissue fibers will be able to capture the alternation between the epochs of higher- or less-aligned
tissue.
1. Mass conservation:
∫
V
L0(p)(t, x, v, y) dv = 0.
2. Self–adjointness: L0 is self–adjoint in L
2( dvM(v) ).
3. Kernel of L0: L0(p) = 0 ⇔ p ∈ 〈M(v)〉, thus Ker(L0) = 〈M(v)〉, the space gener-
ated by M(v). In particular, using the self–adjointness, we know that M⊥ ∈ 〈M(v)〉⊥ iff∫
V
M⊥(v)dv = 0.
Before proceeding with the scaling we re-express (similarly to e.g. [25]) the subcellular dy-
namics in a more convenient way: Let us consider y∗ = f(Q) := k+Qk−+k+Q , the steady-state of
(2.1), and denote by
z := y − y∗
the deviation of the current activity variable y from the steady state. Then z ∈ Z ⊆ [−y∗, 1− y∗]
and the microscopic dynamics (2.4) turns into
dx
dt
= v;
dv
dt
= αB(v)
(∇xq(t, x, vˆ)−∇xh(t, x)); dz
dt
= −(k+Q+ k−)z − f ′(Q)(Qt + v·∇xQ).
Then (2.3) becomes
∂tp+ v·∇xp− ∂z
(
((k+Q+ k−)z + f ′(Q)(Qt + v · ∇Q))p
)
+ αdivv
(
B(v)(∇xq(vˆ)−∇xh)p
)
= λ(x, z)L0(p) + P(p,Q, h, ρ), (3.16)
where the turning rate in terms of z is given by λ(x, z) = κ(z+f(Q(t,x)))FA+z+f(Q(t,x)) . To simplify the
subsequent computations we linearize it as follows:
λ(t, x, z) ' λ0(t, x) + λ1(t, x)z, where λ0(t, x) = κf(Q)
FA+ f(Q)
and λ1(t, x) =
κFA
(FA+ f(Q))2
.
Remark 3.1 Notice that the fractional anisotropy FA changes dynamically, i.e. depend both
on t and x, since tissue evolution (here this means degradation) leads to local modifications of
the water diffusion tensor and, correspondingly, of its eigenvalues. Indeed, the apparent diffusion
tensor can even vanish locally, in which situation the cell diffusivity degenerates. In hitherto
works [22,23,25–27,41–43,72] FA has been assumed to be time-independent, motivating that the
resolution of DTI data does rarely go below voxels with sizes of 1 mm3, which is rather rough
compared with the size of glioma cell bodies (15-60 µm, [56]). This simplifies the numerical
handling and also avoids problems related to the possibly singular behavior of solutions to the
macroscopic PDE, as systems with degenerating myopic diffusion and haptotaxis can lead to
blow-up even in 1D [87,88]. In Section 4, however, we will consider several simulation scenarios,
including, in turn, evolving and time-stationary tissue, and compare their outcome.
3.1 Parabolic limit, undirected tissue
The parabolic scaling corresponds formally to the change of variables t → ε2t, x → εx. We
perform it and thereby rescale as in [26] the source term P(p,Q, h, ρ) with ε2, in order to let it
act on the correct time scale. Correspondingly, equation (3.16) becomes:
ε2∂tp+ ε∇x · (vp)− ∂z
(
((k+Q+ k−)z + f ′(Q)(ε2Qt + εv · ∇Q))p
)
+ αεdivv
(
B(v)(∇xq(vˆ)−∇xh)p
)
= λ(t, x, z)L0(p) + ε
2µ(ρ, h)Q(t, x)
∫
Z
χ(x, z, z′)p(t, x, v, z′)dz′. (3.17)
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Next we consider the moments of p with respect to v and especially with z:
m(t, x, v) :=
∫
Z
p(t, x, v, z)dz, mz(t, x, v) :=
∫
Z
zp(t, x, v, z)dz, ρz(t, x) =
∫
V
mz(t, x, v)dv
p¯(t, x, z) :=
∫
V
p(t, x, v, z)dv, ρ(t, x) :=
∫
V
m(t, x, v)dv =
∫
Z
p¯(t, x, z)dz
and neglect the higher order moments with respect to z by assuming very small deviations of
the receptor binding dynamics from the steady-state, i.e. by assuming z to be very small. As
the subcellular dynamics is very fast in comparison to cell motion and proliferation, this is a
reasonable assumption.
Then from (3.17) we obtain the moment equations:
ε2∂tm+ ε∇x · (vm) + αεdivv
(
B(v)(∇xq(vˆ)−∇xh)m
)
= λ0(t, x)(M(v)ρ−m)
+ λ1(t, x)(M(v)ρ
z −mz) + ε2µ(ρ, h)Q(t, x)
∫
Z
∫
Z
χ(x, z, z′)p(t, x, v, z′)dz′dz (3.18a)
ε2∂tm
z + ε∇x · (vmz) + αεdivv
(
B(v)(∇xq(vˆ)−∇xh)mz
)
+ (k+Q+ k−)mz + εf ′(Q)v · ∇Qm
+ ε2f ′(Q)mQt = λ0(t, x)(M(v)ρz −mz) + ε2µ(ρ, h)Q(t, x)
∫
Z
∫
Z
zχ(x, z, z′)p(t, x, v, z′)dz′dz
(3.18b)
Performing the usual Hilbert expansion p =
∑
k
εkpk and consequently the expansion of the
moments:
m =
∑
k
εkmk, m
z =
∑
k
εkmzk, ρ =
∑
k
εkρk, ρ
z =
∑
k
εkρzk (3.19)
and identifying the powers of ε we obtain from (3.18a) and (3.18b) the following relationships:
0 terms:
0 = λ0(M(v)ρ0 −m0) + λ1(M(v)ρz0 −mz0)
(k+Q+ k−)mz0 = λ0(M(v)ρ
z
0 −mz0) ⇒ ρz0 = mz0 = 0 and M(v)ρ0 = m0.
1 terms:
∇x · (vm0) + αdivv
(
B(v)(∇xq(vˆ)−∇xh)m0
)
= λ0(M(v)ρ1 −m1) + λ1(M(v)ρz1 −mz1)
∇x · (vmz0) + αdivv
(
B(v)(∇xq(vˆ)−∇xh)mz0
)
+ (k+Q+ k−)mz1 + f
′(Q)v · ∇Qm0 = λ0(M(v)ρz1 −mz1).
Integrating with respect to v we obtain (for undirected tissue)
ρz1 = 0, m
z
1 = −
M(v)ρ0
k+Q+ k− + λ0
f ′(Q)v · ∇Q, (3.20a)
m1 =
1
λ0
[
−∇x · (vM(v)ρ0)− αdivv
(
B(v)(∇xq(t, x, vˆ)−∇xh)M(v)ρ0
)
− λ1mz1
]
(3.20b)
+M(v)ρ1. (3.20c)
2 terms from (3.18a), after expanding µ about ρ0 and integrating the equation with respect to
v:
∂tρ0 +∇x ·
∫
V
vm1dv = µ(ρ0, h)Qρ0.
From (3.20) we can compute∫
V
vm1dv =
1
λ0
[
−∇x · (
∫
V
v ⊗ vM(v)dvρ0)
− α
∫
V
vdivv
(
B(v)(∇xq(t, x, vˆ)−∇xh(t, x))M(v)ρ0
)
dv
+
λ1f
′(Q)
k+Q+ k− + λ0
∫
V
v ⊗ vM(v)dv∇Qρ0
]
.
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We denote by
E˜q(t, x) :=
∫
V
v
q(t, x, vˆ)
ω
dv = s
∫
SN−1
θq(t, x, θ)dθ = sEq(t, x) (3.21)
and with
DT (t, x) :=
∫
V
(v − E˜q)⊗ (v − E˜q)M(t, x, v) dv =
∫
V
(v − E˜q)⊗ (v − E˜q)q(t, x, vˆ)
ω
dv (3.22)
the so-called tumor diffusion tensor5. In the situation with undirected tissue we have Eq(t, x) = 0,
thus in this case DT (t, x) = s2Vq(t, x), where Vq denotes the variance-covariance matrix w.r.t.
the fiber orientation distribution q. With the notation
g(Q,λ0)(t, x) :=
f ′(Q)
k+Q+ k− + λ0
,
we have ∫
V
vm1dv = − 1
λ0
∇x · (DT ρ0) + λ1
λ0
g(Q,λ0)DT∇Qρ0 + α
λ0
Σ(t, x)ρ0, (3.23)
with Σ(t, x) := S1(t, x; q)− S2(t, x;h), where
S1(t, x; q) :=
∫
V
B(v)∇xq(t, x, vˆ)M(t, x, v)dv = 1
ω
∫
V
B(v)∇xq(t, x, vˆ)q(t, x, vˆ)dv (3.24a)
S2(t, x;h) :=
∫
V
B(v)M(t, x, v)dv ∇xh(t, x) = s2(IN − Vq(t, x))∇xh(t, x). (3.24b)
Then, the limiting macroscopic equation for the tumor cell density takes the form
∂tρ0 = ∇ ·
[ 1
λ0(x)
(
∇ · (DT ρ0)− λ1(x)g(Q,λ0)DT∇Qρ0 − αS1(t, x; q)ρ0
+αS2(t, x;h)ρ0
)]
+ µ(ρ0, h)Qρ0. (3.25)
The obtained equation is of drift-diffusion type; the first term on the right hand side represents
a non-Fickian, so-called myopic diffusion: the cells spread out according to information available
in their immediate surroundings. The next two terms feature a sign opposite to the myopic
diffusion and represent drift corrections of the diffusive part in the direction of the macroscopic
and mesoscopic tissue gradients ∇Q and ∇q, respectively. They could therefore be interpreted
as haptotaxis-like terms. The first of them carries through the function g the influence of the
subcellular receptor binding dynamics to the surrounding tissue, while the remaining drift term
accounts for the (mesoscopic) stress exerted by the cells on the tissue, the latter being described
by the directional distribution of fibers q. The drift term involving S2 in (3.25) has the same
sign with the diffusion, and contains a bias towards the opposite direction of acidity gradient
∇h, thus describes a repellent pH-taxis. The information about the brain tissue structure, which
is decisive for personalized predictions of the tumor space-time evolution, is contained in (3.25)
via the tumor ’diffusion’ tensor DT and the vector S1(t, x; q), which in view of (2.4) can be seen
as a biomechanical interaction force between tumor cells and tissue. Thereby, the stress tensor
B(v) contributes (together with the kernel M(t, x, v) = q(t,x,vˆ)ω ) to the (mesoscopic) haptotactic
sensitivity of the cells, which is expressed here in a velocity-averaged way. The last term in
(3.25) encodes proliferation and decay of glioma embedded in tissue. The function µ(ρ0, h) can
be correspondingly chosen, e.g. in the form
µ(ρ0, h) = η(1− ρ0 − n)(hT − h)+ − γh, (3.26)
which would correspond to a logistic type of growth and a hypoxia-triggered necrosis. Thereby
η, γ > 0 are constants and hT denotes an acidity threshold which is critical for the cancer cells:
5This designation is somewhat abusive, since here -unlike previous works [25–27,72]- the turning rate is not involved
in its expression, due to its dependence on the position. When writing out the myopic diffusion it becomes evident
that the ’actual’ diffusion tensor is DT /λ0.
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when the proton concentration exceeds it, they become hypoxic and cease proliferation. The
choice of µ establishes the form of the last source term in (2.15). Thus, with (3.26) we have in
the equation for necrotic tissue
F(h, ρ,Q) = γhρQ. (3.27)
The role of the turning rate λ is twofold: it connects the cell reorientations to the recep-
tor binding kinetics and it also captures the effect of tissue anisotropy on the cells migrating
through the tissue. While λ0 influences all motility terms, λ1 is specific for the haptotaxis com-
ponent including subcellular level effects. The factor 1λ0 is independent on y and increasing with
the space-varying fractional anisotropy FA, the effect of which is particularly accentuated in
the term multiplied with λ1. This means that λ1 with the inherent y-dependence provides an
anisotropy-triggered switch between myopic diffusion with ’mesolevel’ haptotaxis and migratory
mode with enhanced haptotaxis, the latter supplementary providing bias in the direction of the
tissue gradient. Observe that an almost isotropic tissue lets λ0 be near constantly κ and nearly
turns off λ1 and therewith the influence of subcellular dynamics. In this case, without the effect
of S1(t, x; q) there would only be myopic diffusion, as e.g., in [72].
3.1.1 Boundary conditions and the full macro-meso system
So far we considered the space variable x ∈ RN , however the brain occupies a well delimited
region inside the skull. Therefore we consider a bounded space domain Ω ⊂ RN and assume it
to have a smooth enough boundary. Through the rescaling x → εx the domain on which (3.25)
holds is Ω˜ = εΩ, having outer unit normal vector ν(x) at x ∈ ∂Ω˜. In order to determine the
corresponding boundary conditions on ∂Ω˜ we assume that there is no normal mass flux across
the boundary [59], which translates into the mesoscopic no-flux condition [74]∫
V
vp(t, x, v, z) · ν(x) dv = 0, for all x ∈ ∂Ω˜, t > 0. (3.28)
This condition actually means that the normal component of the macroscopic ensemble ve-
locity U(t, x) =
∫
V
vm(t, x, v)dv of the tumor across the space boundary vanishes (the tumor
cannot leave the brain). Following [74] we write the boundary of the phase space as
∂Ω˜× V × Z = (Γ+ ∪ Γ− ∪ Γ0)× Z,
where
Γ± := {(x, v) ∈ ∂Ω˜× V : ±v · ν(x) > 0}, Γ0 := {(x, v) ∈ ∂Ω˜× V : v · ν(x) = 0}.
We assume that Γ0 has zero measure w.r.t. the Lebesgue measure on ∂Ω˜ × V and consider
the trace spaces
L2± := L
2(Γ± × Z; |v · ν(x)|dσ(x)dvdz).
Moreover, p is supposed to be regular enough so that we can define the traces p|Γ±×Z ∈ L2±,
and that for a fixed t > 0
p|∂Ω˜×V×Z(t, x, v, z) = lim
x˜∈Ω˜
x˜→x
p(t, x˜, z), for each x ∈ ∂Ω˜.
Assuming that a regular Hilbert expansion is valid in Ω˜ we can therefore compute the trace by
simply passing to the corresponding limit in the Hilbert expansions for p(t, x, v, z) and accordingly
also for the moments (3.19). Thus, the no-flux condition (3.28) becomes∫
V
v(p0(t, x, v, z) + εp1(t, x, v, z))dv · ν(x) +O(ε2) = 0, x ∈ ∂Ω˜, z ∈ Z, t > 0.
This condition should not depend on ε, therefore we should have∫
V
vpj(t, x, v) · ν(x)dv = 0 for all j ≥ 0, x ∈ ∂Ω˜, z ∈ Z, t > 0.
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Indeed, for j = 0 we already have this condition satisfied for undirected tissue:∫
Z
∫
V
vp0(t, x, v, z)dvdz · ν(x) =
∫
V
vm0(t, x, v)dv · ν(x)
=
∫
V
v
q(t, x, vˆ)
ω
ρ0(t, x)dv · ν(x)
= ρ0E˜q(t, x) · ν(x) = 0.
Next we look at the condition for j = 1, more precisely at its integration w.r.t. z:∫
Z
∫
V
vp1(t, x, v, z)dvdz · ν(x) =
∫
V
vm1(t, x, v)dv · ν(x)
(3.23)
=
(
− 1
λ0
∇x · (DT ρ0) + λ1
λ0
g(Q,λ0)DT∇Qρ0 + α
λ0
Σ(t, x)ρ0
)
· ν(x),
which leads to a typical no-flux boundary condition(
− 1
λ0
∇x · (DT ρ0) + λ1
λ0
g(Q,λ0)DT∇Qρ0 + α
λ0
Σ(t, x)ρ0
)
· ν(x) = 0 on ∂Ω˜, t > 0 (3.29)
for the macroscopic PDE (3.25). This equation is coupled with the dynamics of acidity h by way
of S2(t, x;h) in Σ(t, x). For this ab initio macroscopic equation we can directly impose a no-flux
condition:
DH∇xh = 0 on ∂Ω˜, t > 0. (3.30)
In previous works [25–27, 38–40] the quantities relating to the tissue, i.e. q and (where ap-
plicable) Q were assumed to be time-invariant, whereby Q itself was estimated from the DTI
data, as in [25–27, 42]. No tissue degradation was accounted for, and one could also include a
proliferation term, e.g. like in [26]. In this much simplified situation only coupling (3.25) with
(2.5) and using the no-flux boundary conditions given above, the system takes the form of a
Keller-Segel problem with some supplementary drift terms, all of which are linear in ρ0.
When the full evolution of the tissue becomes relevant, then (3.25) and (2.5) have to be
supplementally coupled with the dynamics of q, as given by (2.14), and with that of Q, given by
(2.11). The resulting (reaction-)diffusion-taxis system then characterizes cell, acidity, and tissue
dynamics evolving on two scales (macroscopic and mesoscopic, respectively). Thereby, we deal
with the macroscopic cell density in the first PDE, while (2.14) and (2.11) involve the mesoscopic
quantity p(t, x, v, y), which is inconvenient both for the analysis and the numerics.
Remark that, thanks to property 3 of L0, the Hilbert expansion is equivalent to splitting p
as p(t, x, v, y) = p¯(t, x, y)M(t, x, v) + εM⊥(t, x, v), with
∫
V
M⊥(t, x, v)dv = 0, i.e. the Chapman-
Enskog expansion used in [38]. The leading order of the operator in (2.8) leads to
Πa[q](t, x, θ) '
{ ∫
SN−1 |θ · θ′|q(t, x, θ′)dθ′ for undirected tissue∫
SN−1 θ · θ′q(t, x, θ′)dθ′ for directed tissue,
(3.31)
along with correspondingly rewriting (2.12) as
A[q](t, x) =
∫
SN−1
Πa[q](t, x, θ)q(t, x, θ)dθ. (3.32)
Therewith we obtain from (2.14) the equation
∂tq(t, x, θ) = rD(h)ρ(t, x)q(t, x, θ)
(
Πa[q](t, x, θ)−A[q](t, x)
)
(3.33)
and from (2.13)
∂tQ = rD(h)ρQ (A[q](t, x)− 1) . (3.34)
Thus, in order to determine the dynamics of tumor cells in interaction with the tissue they
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degrade and with the acidity they produce, we have to solve the macro-meso system
∂tρ = ∇x ·
[ 1
λ0(t, x)
(
∇x · (DT ρ)− λ1(t, x)g(Q,λ0)DT∇Qρ− αS1(t, x; q)ρ+ αS2(t, x;h)ρ
)]
+ µ(ρ, h)Qρ (3.35a)
∂tq(t, x, θ) = rD(h)ρ(t, x)q(t, x, θ)
(
Πa[q](t, x, θ)−A[q](t, x)
)
(3.35b)
∂tQ = rD(h)ρQ (A[q]− 1) (3.35c)
ht = DH∆h+
aρ
1 + ρ
− bQ(h− h0) (3.35d)
∂tn = rD(h)ρQ (1−A[q]) + F(h, ρ,Q), (3.35e)
where DT is as in (3.22) with Eq = 0, with S1 and S2 as in (3.24), Πa[q] as in (3.31), A[q]
as in (3.32), µ as in (3.26), F as in (3.27), with boundary conditions (3.29), (3.30), and with
given initial conditions ρ(0, x), q(0, x, θ), Q(0, x), h(0, x), and n(0, x). These can be the tumor
cell distribution (or an approximation of it) observed at diagnosis, the directional distribution of
fibers obtained via DTI, some estimate of the macroscopic volume fraction of the tissue (e.g., most
simply FA, as in [23, 25]), some (estimated) acidity distribution at diagnosis, and the necrotic
tissue distribution, respectively. A tumor segmentation of the diagnosis image could be useful in
assessing the latter.
The mathematical handling of system (3.35) is nontrivial, both with respect to well posedness
and numerics. The equations connect two modeling levels (macroscopic and mesoscopic) and the
couplings via q involved in the coefficients of all terms on the right hand side of (3.35a) render the
problem highly nonlinear. Moreover, the equation for ρ features (along with the myopic diffusion)
three types of taxis:
• macroscopic haptotaxis towards ∇Q,
• a new kind of mesoscopic haptotaxis (term with S1), where the bias is actually given by
∇xq2, and
• pH-taxis, describing chemorepellence due to acidity (term with S2).
3.2 Moment closure for the fiber equation
The system (3.35) is macroscopic with respect to the cell dynamics: by an asymptotic expansion
of p(t, x, v, y) around the local Maxwellian q(t, x, θ), we derived a model for the local cell density
ρ(t, x). However, the tissue is modeled by the mesoscopic quantity q(t, x, θ). To reduce the level
of detail in the tissue dynamics to match the rest of the model, we derive a low-order moment
approximation to (3.35b). For simplicity, we only consider the two-dimensional case.
Recall the peanut distribution [38,72]:
q(θ) =
1
〈θ>DW θ〉θ
>DW θ =
1
pi trDW
θ>DW θ.
We interpret this as a P2-approximation [15] [75, III.5] under some additional constraints. A
second-order basis of monomials is given by
a =
(
θx θy θ
2
x θxθy θ
2
y
)
.
We drop the constant function from the basis, because it would introduce a linear dependence:
θ2x + θ
2
y = 1. The P2 ansatz is defined by the linear combination of basis functions
q(θ) = α · a,
wherein α is a vector of multipliers such that the moment constraints
u := 〈aq〉 = 〈aq〉 = 〈aa>〉 k
are fulfilled. Due to the symmetry constraints 〈θq〉 = 0, we drop the first-order monomials θx, θy
from the basis. The remaining basis functions are then:
b =
(
θ2x θxθy θ
2
y
)
.
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With this choice it is easy to associate the multipliers β in the ansatz
q = β · b(θ)
with the components of the normalized water diffusion tensor:
β :=
(
βxx βxy βyy
)
=
1
pi trDW
(
DWxx 2DWxy DWyy
)
.
Moreover, the moments w := 〈bq〉 are directly related to the components of the (normalized)
tumor diffusion tensor P =
〈
θθ>q
〉
:
w :=
(
wxx wxy wyy
)
=
(
Pxx Pxy Pyy
)
.
We can translate multipliers to moments with the moment constraints w = 〈bq〉 = 〈bb>〉β . The
transfer matrix is given by
H :=
〈
bb>
〉
=
pi
4
3 0 10 1 0
1 0 3
 .
With these tools in hand, we derive a P2-approximation of the tissue dynamics (3.35b) through
the following steps: Insert the ansatz q into (3.35b), multiply by the basis b and integrate over
S1 to obtain
∂tw = rD(h)ρ (〈bqΠ [q]〉 −wA [q]) . (3.36)
It remains to calculate the moments 〈bqΠ [q]〉. Inserting the definitions of q and Π, we obtain
〈bqΠ [q]〉 =
∫
S1
∫
S1
b(θ)β · b(θ)β · b(θ′)|θ · θ′|dθ′dθ.
With the tensor
Pk,ij =
∫
S1
∫
S1
bk(θ)bi(θ)bj(θ
′)|θ · θ′|dθ′dθ
we can write the k-th component 〈bqΠ [q]〉k as
〈bqΠ [q]〉k = β>Pkβ = w>
(
H−1>PkH−1
)
w.
Finally, we obtain A [q] from the identity θ2x + θ
2
y = 1:
A [q] = 〈1qΠ [q]〉 = 〈(θ2x + θ2y)qΠ [q]〉 = 〈bqΠ [q]〉xx + 〈bqΠ [q]〉yy .
The tensor Pk,ij can be precomputed once and for all with a high-order quadrature. To evaluate
each component of the right-hand side of (3.36) we need to compute only a quadratic form at run
time. Note that the normalization 〈q〉 = 1 results in the loss of an additional degree of freedom.
It holds trP = 1, therefore we can reconstruct wyy = 1− wxx and only need the evolve the two
moments wxx, wxy in (3.36).
Remark: In three dimensions, the previous considerations are completely analogous for the
basis b =
(
θ2x θ
2
y θ
2
z θxθy θxθz θyθz
)
.
3.3 Hyperbolic scaling, directed tissue
Here we also aim to investigate the effect of reducing diffusivity that might not be experimentally
consistent. In order to achieve this objective and for the sake of completeness, we propose in this
subsection to perform a hyperbolic limit that will provide us with a macroscopic vision in which
the terms of transport and potentials win the battle over diffusion. We will take advantage of
most of the calculations in Subsection 3.1, that we will omit in part so as not to be repetitive.
Finally, in order to try to model a series of effects of a priori minor influence according to the
experiments, not contemplated in the model variables, we carry out a ”small” extension to the
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second order of the hyperbolic expansion and compare this double development on the scale with
the parabolic approach.
In the following we address a version of (3.16) where we neglect the dependence of the turning
rate on the subcellular dynamics, i.e. we consider it to be of the form λ(x) = κFA(x)+1 and are
interested in the situation of directed tissue.
We thus consider the kinetic transport equation
∂tp+ v·∇xp− ∂z
(
((k+Q+ k−)z + f ′(Q)(Qt + v · ∇Q))p
)
+ αdivv
(
B(v)(∇xq(vˆ)−∇xh)p
)
= λ(x)L0(p) + P(p,Q, h, ρ), (3.37)
with L0(p) = p¯(t, x, z)
q(x,vˆ)
ω − p(t, x, v, z) having the same properties as in Subsection 3.1 and
perform a hyperbolic scaling t→ εt, x→ εx, while the proliferation term is rescaled as previously
with ε2. This leads to
ε∂tp+ εv·∇xp− ∂z
(
((k+Q+ k−)z + εf ′(Q)(Qt + v · ∇Q))p
)
+ αεdivv
(
B(v)(∇xq(vˆ)−∇xh)p
)
= λ(x)L0(p) + ε
2P(p,Q, h, ρ). (3.38)
We now consider a Chapman-Enskog expansion (equivalent here to the Hilbert one, as stated
in Subsection 3.1), i.e., a decomposition of p into a Ker(L0)-component and a Ker(L0)
⊥-part,
as follows:
p(t, x, v, z) = p¯(t, x, z)
q(t, x, vˆ)
ω
+ εp⊥(t, x, v, z), (3.39)
where p⊥ ∈ 〈 qω 〉⊥ verifies ∫V p⊥(t, x, v, z)dv = 0. This decomposition leads to the corresponding
expansion for the moments of p, in particular: m(t, x, v) = ρ(t, x) q(t,x,vˆ)ω + εm
⊥(t, x, v, z), and
then, integrating (3.38) w.r.t. z ∈ Z we obtain
ε∂tρ
q
ω
+ ερ∂t(
q
ω
) + ε2∂tm
⊥ + εv · ∇x(ρ q
ω
) + ε2v · ∇xm⊥+αε∇v ·
(
B(v)(∇xq(vˆ)−∇xh)m
)
= ελ(x)L0(m
⊥) + ε2µ(ρ, h)Qm.
(3.40)
Integrate w.r.t. v and divide by ε to get
ρt +∇x · (ρE˜q + ε
∫
V
vm⊥dv) = ερµ(ρ, h)Q, (3.41)
where as before E˜q(t, x) =
∫
V
v q(t,x,vˆ)ω dv = sEq(t, x).
Clearly (3.41) is drift-dominated; however, it is worth computing the O(ε) correction with
respect to the pure drift. From (3.40) and (3.41) follows
λ(x)L0(m
⊥) = ε
q
ω
ρµ(ρ, h)Q− q
ω
∇x ·
(
ρE˜q + ε
∫
V
vm⊥dv
)
+ ρ
∂tq
ω
+ ε∂tm
⊥ + v · ∇x(ρ q
ω
+ εm⊥)
+α∇v ·
(
B(v)(∇xq(vˆ)−∇xh)m
)
− ερµ(ρ, h)Q. (3.42)
Now observe that the integral w.r.t. v of the right hand side in (3.42) vanishes, so that we
can take the (pseudo)inverse of L0 giving (at leading order)
m⊥ '− 1
λ(x)
[ q
ω
(v − E˜q) · ∇ρ+ ρ
(
v · ∇x q
ω
− q
ω
∇x · E˜q
)
+ ρ
∂tq
ω
(3.43)
+ α∇v ·
(
B(v)(∇xq(vˆ)−∇xh)m
)]
, (3.44)
hence ∫
V
vm⊥dv ' − 1
λ(x)
(∫
V
v ⊗ (v − E˜q) q
ω
dv ∇ρ (3.45)
+ ρ
(
∇x ·
∫
V
v ⊗ v q
ω
dv − E˜q∇x · E˜q
)
+ ρ∂tE˜q − αρΣ(t, x)
)
= − 1
λ(x)
(
∇x · (DT ρ)− ρE˜q∇x · E˜q + ρ∂tE˜q − αρΣ(t, x)
)
, (3.46)
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where DT (t, x) and Σ(t, x) := S1(t, x; q) − S2(t, x;h) are as introduced in Section 3.1 and we
observe that ∫
V
v ⊗ (v − E˜q) q
ω
dv =
∫
V
(v − E˜q)⊗ (v − E˜q) q
ω
dv = DT .
Together with (3.41) this leads to the macroscopic PDE
ρt+∇·(ρE˜q) = ε∇·
(
1
λ(x)
(
∇·(ρDT (t, x))+ρ(∂tE˜q−E˜q∇·E˜q−αΣ(t, x))
))
+ερµ(ρ, h)Q, (3.47)
which is drift-dominated. Notice that for Eq = 0, i.e. if the tissue is undirected, the correction
term in (3.47) has the same form as the right hand side of (3.25) - except for the middle term
therein, which got lost when integrating (3.38) w.r.t. z. In fact, it was the assumption of the
turning rate not depending on z which effaced the whole influence of subcellular dynamics. The
effect of this is not having the macroscopic haptotaxis term in the ε-correction on the right
hand side. Nevertheless we still get the pH-taxis and (mesoscopic) haptotaxis correction terms
contained in
ε∇ ·
( α
λ(x)
ρΣ(t, x)
)
= ε∇ ·
( α
λ(x)
ρ(S1(t, x; q)− S2(t, x;h))
)
.
Coupling (3.47) with the equations (3.35b) and (3.35d) describing tissue and acidity evolution,
respectively, leads to challenges similar to those in Section 3.1.
We need to prescribe boundary conditions. To this aim we consider again a bounded, suffi-
ciently smooth domain Ω˜ = εΩ ⊂ RN and start from a mesoscopic no-flux condition of the form
(3.28). Using the Chapman-Enskog expansion (3.39) of p(t, x, v, z) we rewrite this condition as(
ρ(t, x)E˜q(x) + ε
∫
Z
∫
V
vp⊥(t, x, v, z)dvdz
)
· ν(x) = 0, for all x ∈ ∂Ω˜, t > 0,
which in virtue of (3.45) leads to(
− ρE˜q + ε
λ(x)
(
∇ · (ρDT (t, x)) + ρ(∂tE˜q − E˜q∇ · E˜q − αΣ(t, x))
))
· ν(x) = 0, x ∈ ∂Ω˜, t > 0,
(3.48)
meaning that the normal macroscopic flux and its ε-correction vanish on the spatial boundary.
Thus, in the case with directed tissue and when no subcellular dynamics are taken into
account, the macro-meso system to be solved becomes
ρt + s∇ · (ρEq) = ε∇ ·
(
s2
λ(x)
(
∇ · (ρVq(t, x)) + ρ(1
s
∂tEq − Eq∇ · Eq − α
s2
Σ(t, x))
))
+ ερµ(ρ, h)Q
(3.49a)
ht = DH∆h+
aρ
1 + ρ
− bQ(h− h0) (3.49b)
∂tq(t, x, θ) = rD(h)ρ(t, x)q(t, x, θ) (Π[p](t, x, θ)−A[p](t, x)) , (3.49c)
∂tQ = rD(h)ρQ(A[p]− 1) (3.49d)
∂tn = rD(h)ρQ (1−A[p]) + F(h, ρ,Q), (3.49e)
with Π[p] and A[p] as given in (2.8) and (2.12), respectively. Observe that upon assuming the
tisue to be undirected (i.e. that Eq = 0), (3.49a) takes the form of (3.35a), which was obtained by
parabolic scaling, with the difference of the right hand side of the glioma dynamics being scaled
here by ε.
As for the parabolic limit, in (3.49) the dependence of the featured operators on the mesoscopic
cell distribution function p is inconvenient, so we use the same approach as in Subsection 3.1.1
to approximate Π[p] and A[p] by (3.31) and (3.32), respectively. Notice that in the present case
(directed tissue) we can rewrite
Πa[q](t, x, θ) = θ · Eq(t, x)
A[q](t, x) = Eq(t, x) · Eq(t, x)
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Consequently, (3.49c) can be replaced by
∂tq(t, x, θ) = rD(h)ρ(t, x)q(t, x, θ)(θ · Eq(t, x)− E2q(t, x)),
hence we can compute
∂tEq = rD(h)ρ(Vq + Eq ⊗ Eq − E2qIN ) · Eq
and plug it into (3.49a). Let us denote
Tq :=
1
s
rD(h)ρ(Vq + Eq ⊗ Eq − E2qIN ) · Eq − Eq∇ · Eq.
Then altogether the system becomes
ρt +∇ · (ρEq) = ε∇ ·
(
s2
λ(x)
(
∇ · (ρVq(t, x)) + ρ(Tq − α
s2
Σ(t, x))
))
+ ερµ(ρ, h)Q (3.50a)
ht = DH∆h+
aρ
1 + ρ
− bQ(h− h0) (3.50b)
∂tq = rD(h)ρq(θ · Eq − E2q) (3.50c)
∂tQ = rD(h)ρQ(E2q − 1) (3.50d)
∂tn = rD(h)ρQ
(
1− E2q
)
+ F(h, ρ,Q), (3.50e)
with θ ∈ SN−1, t > 0, and x ∈ Ω˜. The functions µ(ρ, h) and F(h, ρ,Q) are still those given in
(3.26) and (3.27), respectively. The equations are completed by initial conditions as in Subsection
3.1.1 and by the no-flux boundary conditions ∇h · ν = 0 on ∂Ω˜ and(
− sρEq + s
2ε
λ(x)
(
∇ · (ρVq(t, x)) + ρ(Tq(t, x)− α
s2
Σ(t, x))
))
· ν(x) = 0, x ∈ ∂Ω˜, t > 0.
(3.51)
4 Numerics
In this section the equations obtained by parabolic upscaling are solved numerically. Simulations
are conducted for three scenarios of increasing complexity. In each scenario we describe a set of
assumptions simplifying the equations. This allows for directly investigating the relative impor-
tance of the different effects included in our model. The results are presented in Subsection 4.3.
For convenience we state in brevity the exact macroscopic systems of PDEs for the considered
scenarios:
Scenario 1: We assume that neither q nor Q depend on time, thus can be assessed from the DTI data.
We follow previous works, starting from a pre-assigned directional distribution q (peanut)
and independently estimate Q using the approach in [26,41,42] relying on Brownian motion
description of water molecule diffusion.6 The system then reduces to (3.35a), (3.35d), merely
featuring myopic diffusion, pH-taxis, and transport terms with drift velocities computed
from the data, together with the necrosis dynamics (3.35e) with rD(h) = 0, i.e.
∂tρ =∇x ·
[ 1
λ0(x)
(
∇x · (DT ρ)− λ1(x)g(Q,λ0)DT∇Qρ− αS1(t, x; q)ρ+ α
h0
S2(t, x;h)ρ
)]
+Qρη(1− ρ− n) (hT − h)+
h0
− γ h
h0
ρQ (4.52a)
∂th =DH∆h+
aρ
1 + ρ
− bQ(h− h0) (4.52b)
∂tn =F(h, ρ,Q). (4.52c)
6Alternative, more precise ways to assess the (macroscopic and/or mesoscopic) tissue density from DTI data would
be to perform density estimation by using statistical or variational methods, see e.g. [24, 30, 50, 90]. Here we do not
address this issue, as our focus is on providing a continuous approach to modeling glioma growth and spread which is
amenable to efficient computations and at the same time able to capture lower scale effects.
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Scenario 2: Q evolves in time, meaning that the tissue is degrading irrespective of the fibre orientations
(hence the anisotropy does not play any role in the degradation). Here A[q] is zero. This
corresponds to an indirect depletion, i.e. not upon contact with glioma cells, but rather
through the acidity they produce. Consequently, the macroscopic system (3.35) simplifies
to
∂tρ =∇x ·
[ 1
λ0(x)
(
∇x · (DT ρ)− λ1(x)g(Q,λ0)DT∇Qρ− αS1(t, x; q)ρ+ αS2(t, x;h)ρ
)]
+Qρη(1− ρ− n) (hT − h)+
h0
− γ h
h0
ρQ (4.53a)
∂tQ =− rD(h)ρQ (4.53b)
∂th =DH∆h+
aρ
1 + ρ
− bQ(h− h0) (4.53c)
∂tn =rD(h)ρQ+ F(h, ρ,Q). (4.53d)
Scenario 3: Both q and Q evolve and the full system (3.35) is solved.
4.1 Numerical discretization
The equations were discretized by the method of lines approach in all three cases. For the
spatial discretization we used a vertex centered finite volume method. The mesh is naturally
structured because of the underlying medical dataset. The mesh width h = 2mm is imposed by
the particular DTI dataset, which is publicly available [17]. The reconstructed diffusion tensors
were averaged with a component-wise arithmetic mean at the control volume interfaces. The
advective fluxes were approximated by a first order upwind discretization. The no-flux barrier
between the brain and the background were implemented by suppressing flux assembly at the
relevant cell interfaces7. The integration of the reaction terms coupling the evolving fields was
performed by a first order midpoint rule at the cell centers. As an initial condition we used a
small Gaußian peak as an approximation of the tumor and took for the spatial distribution of the
acidity field h the uniform steady-state of (3.35d). The initial condition for necrotic matter was
simply n = 0. The time discretization was realized by an implicit Euler scheme. The resulting
nonlinear system was solved via Newton iteration which internally used a BiCGSTAB solver
preconditioned via AMG with an SSOR smoother [83].
4.1.1 Software
The implementation was performed within the DUNE software framework [3,4], specifically with
the dune-pdelab discretization module [5,12]. The BiCGSTAB solver and the AMG were provided
by the iterative solver template library dune-istl [11].
4.2 Choice of simulation parameters and coefficient functions
In Table 1 we present the parameters used throughout all numerical simulations, their meaning,
and their respective sources. We can also assess the parabolic scaling parameter
ε =
s
κX
' 2 · 10−6,
where we use X = 0.06 m as a reference length, corresponding to the side length of he plots in
e.g., Figure 2). This value indicates that the parabolic limit is an adequate approximation to the
kinetic model for the chosen parameters.
Let us also highlight here the role of the scaling parameter α. It is influenced by the position
gradients of q and h (involved in Σ) and hence should be a large quantity, say of the order 1γ ε
−γ for
some γ > 0. This is similar to what happens when we perform hyperbolic scaling in a fairly similar
kinetic framework (see [8,77]), where hydrodynamic limits with dominant drift are obtained, but
where the small diffusion correction of a non-diffusive limit can be made explicit by displaying
the dependency of ε on all scaling parameters. In the present context γ should be a parameter
related to smaller scales, such as the microtubule (MT) extension zones that are responsible for
the biochemical and biomechanical exchange of cells with their environment [34,54]. The length
7here we mean by ’cell’ the numerical discretization element and not the biological entity
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of microtubules is between 5 and 8 cell units [76], whereas a glioma cell has a diameter of ca.
15µm = 15 × 10−3mm [1]. This means that the regions of MTs that would correspond to the
tumor front have a length around 100µm = 0.1mm. Then, the parameter γ will represent the
ratio of such MT area with respect to the whole tumor; here we take γ = 0.001. Therefore, and
in view of the above choice of ε, the parameter α is taken here of the order of 103.
The coefficient functions involved in the simulations are summarized below:
For all scenarios: F(h, ρ,Q) = γ h
h0
ρQ,
λ0 =
κf(Q)
FA+ f(Q)
, λ1 =
κFA
(FA+ f(Q))2
, f(Q) =
k+Q
k+Q+ k−
f ′(Q) =
k+k−
(k+Q+ k−)2
, g(Q,λ0) =
f ′(Q)
k+Q+ k− + λ0
, rD(h) = r0
(
h
h0
− 1
)
+
.
For Scenario 1: Q(x) = 1−
( tr(DW(x))
λmax
) 3
2
, DT (x) =
s2
(N + 2)
(
IN + 2
DW(x)
tr(DW(x))
)
,
with λmax denoting the maximum eigenvalue of the water diffusion tensor DW .
parameter value meaning source
s 50 (µm/h) (= 1.389e-8 m/s) cell speed [67]
α 103 (1) weight for advective terms estimated
κ 0.1 (1/s) maximum turning frequency estimated
h0 1.0e-7.2 (mol/l) healthy acidity value [84]
hT 1.995e-07 (mol/l) threshold of possible proliferation [84]
DH 0.5e− 03 (mm2/s) diffusion coefficient of protons [60]
a 2.2e− 17 (mol cm3(cells · sec)−1) acid production rate [65]
b 0.8e-04 (1/sec) proton buffering by healthy tissue [64]
η 0.26e-06 (1/sec) tumor proliferation rate [66]
k+ 0.034 (1/sec) attachment rate of tumor cells to tissue [58]
k− 0.01 (1/sec) cell detachment rate [58]
γ 5e-08 (1/sec) acid-induced death rate of tumor cells [81]
r0 1.0e-6 (1/(mol sec)) efficiency of fiber degradation estimated
Table 1: Full set of parameters for the numerical simulations
4.3 Numerical results
We focus the presentation of the numerical results on those aspects where the new model and
its extension, in particular by including tissue dynamics, produce new qualitative effects. Com-
putations were conducted with a simulated time of 52 weeks. We first present line plots from
the coordinate origin through the tumor to the upper right of the domain in order to visualize
and discuss the evolution of the involved fields. This helps to establish the general dynamics
of the model in Subsection 4.3.1. We present the final states of the involved fields in 4.3.2 and
investigate in Subsection 4.3.3 which advective effect is playing a dominant role with respect to
the tumor extent and appearance. We then directly compare the solutions of the three consid-
ered scenarios in Subsection 4.3.4, and address in Subsection 4.3.5 the grading of a tumor upon
relying on the numerical results, particularly with respect to the amount of necrotic matter. We
also suggest in Subsection 4.3.6 how the simulations of the model could be used to perform dose
painting for radiation treatment.
4.3.1 Scenario 3: overall dynamics
Figure 1 shows the amplitude of the four fields ρ, n,Q for densities of tumor cells, necrotic
matter, and macroscopic tissue, respectively, and for the proton concentration field h converted
to its corresponding pH-value (right scale) at three distinct points in time. The uppermost plot
indicates the initial condition we chose for the ρ- and h fields, progressing then downwards with
the simulation time.
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As the tumor density ρ increases due to the proliferation (thus also leading to an increase in
acidity concentration) the cells start to accumulate at the interface with tissue due to pH-taxis
and meso- and macroscopic haptotaxis. The sustained expression of protons (lower pH) leads
to necrotic core formation and growth. The total neoplasm is considered to be made up by the
densities of necrotic matter n and living tumor cells ρ. At the final stage of the simulation, the
former represents the largest part of the neoplasm (n > 0.6), with a comparatively small density
(approx. ρ < 0.2) of living tumor cells. This is consistent with high grade tumors typically
observed in clinical practice [35,78].
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Fig. 1: Profiles of tumor density ρ, acidity h (as pH), necrosis n, and tissue density Q over 52 weeks.
Scenario 3: the tissue is dynamically degraded depending on its local orientation and the acidity
concentration; a necrotic core is formed and develops, becoming the main part of the neoplasm.
Available in color online.
4.3.2 Scenario 3: solution components at the end of simulation
In Figure 2 we show the final states of the four fields of Scenario 3, overlain with the main axis
of the water diffusion tensor Dw from the DTI data sets, as well as the direction of the combined
advective fields. The dominant S2 term describing repellent pH-taxis results in active transport
of tumor mass away from the center. Similarly to the line plots presented earlier in Figure 1, we
can identify a reduction of active tumor cells and tissue degradation within the acidic core area
of the neoplasm, where necrosis is growing instead.
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Fig. 2: Dynamic fields of solution components ρ, pH = − log10(h), n,Q after 52 weeks in a computa-
tion for Scenario 3. Red arrows: main axes of DW . Green arrows: total advection vector. Top left:
density ρ of living tumor cells. Top right: pH value calculated from the acidity field pH = − log10(h).
Bottom left: density n of necrosis. Bottom right: macroscopic density Q of normal tissue. Available
in color online.
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4.3.3 Scenario 3: study of dominant advective effects
To evaluate the relative importance of the four advective terms within the model, we investigated
their dynamically changing magnitudes. We include the dynamic scaling term 1/λ0(x) in these
presentations. Figure 3 shows the fractional anisotropy of the underlying data set, the magnitudes
of S1, S2, and the magnitude of all combined advective terms at 52 weeks simulation time. For
the literature-based parameter set in Table 1 the chemotactic term S2 is orders of magnitudes
stronger than the other advective fields in this late stage of tumor progression. In the bottom
right plot of Figure 3 it can be observed that the dominant advective effect at the proliferation
front is given by S2, while the other effects may only contribute significantly in the absence of
acidity gradients, i.e. beyond the visible tumor margins.
We also investigated in Figure 4 the relative importance of the different advective effects by
successively excluding them in the simulation runs. That way, the total time-integrated effect of
inclusion and exclusion of the terms could be investigated. The repellent pH-taxis described by
the S2-term was found to have the most dominant effect on the tumor density, but the haptotaxis
terms also contribute to establishing low-density areas at the tumor edges. Given the infiltrative
spread of glioma cells and post-treatment tumor recurrence which is mainly due to such relatively
small cell aggregates located further away from the main tumor mass, such margins might be
relevant for treatment planning, especially as far as radiotherapy is concerned (see also Subsection
4.3.6).
4.3.4 Comparison between model scenarios
In the following we compare the simulation results for Scenarios 1-3 with identical initial condition,
in order to find out whether there are any potentially relevant differences. Figure 5 shows the
density ρ+ n of the neoplasm after 52 weeks. As expected, Scenario 3 involving three-fold taxis
and myopic diffusion predicts the largest tumor spread, with the most substantial difference being
that w.r.t. Scenario 1. It is a modeling problem in itself to predict how living cells and necrotic
matter influence the gray scale images in different ways. A direct comparison of Scenarios 2 and
3 with medical images is therefore not possible without knowing the underlying mapping of the
two species to the MRI gray scale imaging. However, the distinction of ρ and n allows deeper
insights into the dynamics of the tumor expansion. The two plots in the second row of Figure 5
illustrate the differences between the densities ρ + n after 52 simulated weeks, computed upon
using Scenarios 3-2, and 3-1. Thus, the latter comparison shows that taking into account the
evolution of normal tissue is of high relevance, while considering the dynamics of mesoscopic tissue
distribution q (i.e the step from Scenario 2 to 3) is contributing less (please note the different
scales of the color maps therein). Hence, the evolution of macroscopic tissue density Q seems to
contribute most to the prediction of tumor spread.
On the other hand, the dynamics of mesoscopic tissue q contributes to substantially modifying
the fractional anisotropy FA, which is a key observable in the DTI imaging of brain tumors. Our
new model allows to directly model the depletion of brain structure and the therewith associated
changes in FA, as indicated in Figure 6. The two plots of the first row show the initial fractional
anisotropy and how it is diminished by the tumor growth after 52 weeks, again overlain by the
direction of the total advective fields. The plot on the second row illustrates the difference in FA
between the final and the initial simulation times.
The results indicate that tissue dynamics can be seen as a downstream effect, after tumor density
and acidity have changed from baseline. The differences in FA are therefore most prominent
closer to the tumor center, and not so much at the invasion edge. Scenario 3 is more complex
and requires more effort to treat, but beyond the differences put in evidence in Figures 5 and 6 it
also provides a framework for a careful description of macroscopic tissue dynamics - along with
its effects on the other solution components.
Still with the aim of investigating the influence of evolving tissue, we also compare a reduced
version of Scenario 3 with a previous model obtained in [72] and accounting for the effect of tissue
anisotropy on the migration of glioma cells, however with fixed tissue. Specifically, we compare
the PDE
ρt = ∇∇ :
(
1
λ0
DT ρ
)
+ ηρ(1− ρ) (4.54)
which is a slight modification of that in [72], by adding the proliferation term and letting λ0 be
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Fig. 3: Top left: fractional anisotropy of the camino dataset [17]. Contours: neoplasm density ρ+n
from Scenario 3 after 52 weeks. Red arrows: main axis of DW . Green arrows: total advection
vector. Top right: magnitude of the S1 term. Bottom left: magnitude of the S2 term. Bottom right:
magnitude of all advective terms (myopic drift, macroscopic haptotaxis, mesoscopic haptotaxis S1,
repellent pH-taxis S2). The scales of the color maps differ between the plots. All advective terms
contain the scaling factor 1/λ0(x). Available in color online.
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Fig. 4: The effect of advective fields on the model predictions. Red arrows: main axis of DW . Green
arrows: total advection vector. All results are obtained for Scenario 3. Top left: simulation result
for the density ρ+n of the neoplasm after 52 weeks. The rest of the plots show absolute differences
in ρ + n between the full model and Scenario 3 without one of the adective terms. Top right: no
macroscopic haptotaxis. Bottom left: no S1 advection. Bottom right: no S2 advection. The scales
of the color maps differ between the plots. Available in color online.
nonconstant, but depend on x like in the rest of this paper, with the system
ρt = ∇ ·
(
1
λ0
∇ · (DT ρ)− λ1g(Q,λ0)DT∇Qρ− αS1(q)ρ
)
+ ηρ(1− ρ) (4.55a)
qt = r0ρq (Πa[q]−A[q]) (4.55b)
Qt = r0ρQ (A[q]− 1) , (4.55c)
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Fig. 5: Comparison of the scenarios. Contours: density ρ + n of the neoplasm computed in the
framework of Scenario 3. Red arrows: main axis of DW . Green arrows: total advection vector.
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both with the same initial conditions and no-flux boundary conditions and the same function
λ0. Figure 4.3.4 shows the computation results. Note that none of the two model makes any
distinction between active and necrotic tumor. The complete tumor mass is encoded in ρ. As
before, the evolution of tissue leads to substantial changes in FA, although the dynamics of acidity
and its influence are absent in these settings. The simulations predict a larger area of glioma
spread when the cells are allowed to degrade the tissue; although there are rather small amounts
of tumor cells in the enlarged regions, these might be relevant for tumor recurrence. Model
(4.54) leads to higher cell densities at the core of the neoplasm, due to the migrating cells only
performing myopic diffusion and not being supplementary driven by haptotaxis.
4.3.5 Tumor grading and importance of tissue evolution
Tumor grade assessment is decisive for the treatment planning of glioma and for patient survival
prognosis. Typically, glioma are classified according to cell activity and tumor aggressiveness,
upon relying on a series of indicators, including histological patterns [14,89] and tumor composi-
tion. Among these, grading by the amount of necrosis relative to the whole tumor volume (both
visible via biomedical imaging) has been addressed e.g., in [35,55,78]. In fact, [35] observed that
’location and volume of tumors were not statistically significant predictors of survival’, which is
in accordance to most conducted studies, as reviewed e.g. in [37]. We therefore address here only
necrosis-based grading. In [35] the percentage of necrotic matter visible on MRI is related to
the total visible tumor volume. An attempt at tumor grading by way of connecting the results
of numerical simulations for our model to this definition proves to be difficult without in-depth
information on how the tissue types (e.g., obtained by segmentation) affect the MRI shading.
The numerical results of our model do not contain any thresholding or shading effects, therefore
we define the time-dependent grade G(t) ∈ [0, 1] of the simulated tumors via:
G(t) :=
Vn(t)
Vn(t) + Vρ(t)
(4.56)
where Vn(t) and Vρ(t) denote integrals over the whole space domain Ω of the necrosis and living
cell densities n(t, x) and ρ(t, x), respectively. We investigate then the evolution of this quantity
over time, upon being guided by the percentage classification in [35]: 0 < G < 25%: grade 1;
25% ≤ G < 50%: grade 2; G ≥ 50: grade 3, with the highest grade corresponding to the most
aggressive tumor and the poorest prognosis.
Figure 8 illustrates the evolution of the tumor grade for the three considered scenarios. We
found only tiny differences between the grades for Scenarios 2 and 3, whereas the difference in
tumor grade progression between Scenarios 1 and 2 is substantial. The definition (4.56) of grade
G effectively skips grade 0, as there is no threshold on the visibility of the necrotic tissue density
n. The fact that Scenario 1 fails to predict tumor progression into grade 3 in due (biomedically
realistic) time might be an indicator of Scenario 1 being insufficient for modeling glioma dynamics,
thus endorsing the role played by tissue evolution.
4.3.6 Dose painting
Beyond tumor grading based on assessment of necrotic matter and heterogeneity of the neoplasm,
the model can provide valuable information about the extent and shape of the tumor and hence
help establishing the contours for radiation treatment. The ability to predict space-time densities
of clonogens as well as necrosis opens the way for more accurate tumor segmentation and dose
painting. Figure 9 shows a gray scale image of the computed neoplasm (ρ+n) for a simulated time
of 52 weeks. Level sets for the density of living glioma cells are shown, thus providing information
about the regions where higher radiation doses should be applied in order to eradicate the active
cells, at the same time sparing areas where their density is lower (either as a consequence of
necrosis - in the tumor core, or due to less cells having invaded the healthy tissue at the tumor
margins).
5 Discussion
We proposed in this paper a novel model for glioma invasion, which takes into account the
interaction with the biochemical and biophysical tumor microenvironment, represented here by
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Fig. 6: Tissue dynamics in Scenario 3. Contours: neoplasm density ρ + n from Scenario 3. Red
arrows: main axis of DW . Green arrows: total advection vector. Top left: gray scale plot of FA
at the start of the simulation. Top right: FA after 52 weeks, with visible reduction of anisotropy
closer to the tumor centre. Bottom left: difference in FA between final and initial simulation times.
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Fig. 7: Comparison between models (4.55) and (4.54). Contours: tumor density ρ from the com-
putation of (4.55) (purple: ρ = 0.1, blue: ρ = 0.25, green: ρ = 0.5). Red arrows: main axis of
DW . Green arrows: total advection vector. Top left: tumor density ρ at the final time (52 weeks)
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puted with model (4.55) and with model (4.54). Bottom right: Difference in FA between end and
beginning of simulation, computed with model (4.55). Available in color online.
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Fig. 8: Grade of tumor (4.56) for the three considered Scenarios. G is essentially the same for
Scenarios 2 and 3, whereas in Scenario 1 (with the same parameter choice) it exhibits significantly
slower progress. Full information is assumed, so that there is no visibility threshold. Scenario 1
predicts the progression from grade 1 towards grade 2 after about 28 weeks, whereas in Scenarios
2 and 3 it needs only about 5 weeks. The progression to grade 3 occurs after about 16 weeks for
Scenarios 2 and 3. For Scenario 1 it does not happen within the simulated time of 52 weeks (recall
that the median survival time of patients with glioma is approx. 60 weeks [91]).
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Gray scale image: density of neoplasm ρ+ n, computation from the reduced Scenario 3, simulation
of 52 weeks. Level sets: ρ = 0.1 (yellow) and ρ = 0.075 (green).
acidity acting as a repellent and, respectively, oriented tissue fibers guiding the cell migration.
Both environmental components, most prominently the acidity, also influence the growth or
depletion of tumor cells.
The modeling approach has a multiscale character: it starts from ODE descriptions of single
cell (position, velocity, activity variable) dynamics, which are translated into a kinetic transport
equation for the space-time distribution function of cells sharing the same regimes of velocity and
activity variables, and eventually arrives at a macroscopic PDE for the evolution of the whole
tumor as a population of such cells performing myopic diffusion and multiple taxis. The cell
behavior is thereby dynamically coupled to that of the environment, the latter featuring a system
of macroscopic and mesoscopic (integro-)differential equations with dependencies on space, time,
and orientation of tissue fibers. We refer to [52] for a review of existing models of cell migration
with multiple taxis and therewith associated challenges. The diffusion and taxis coefficients of
the PDE obtained here for the cell density and the source terms of the equations for meso- and
macrocopic tissue and necrosis densities involve nonlocalities w.r.t. the orientations of tissue
fibers and cell velocities; see [20] for a review of models for cell migration involving this and other
types of nonlocality.
There are several alternative ways to include cell level environmental influences in a KTAP
modeling framework, ultimately leading in the macroscopic limit to taxis terms:
(i) by using in the operator describing velocity reorientations turning rates which depend on
the pathwise gradient of one or several signals, as done e.g. in [63,70];
(ii) by describing the dynamics of activity variables for the cell state, which translates into
corresponding transport terms in the kinetic equations and turning rates depending on the
activity variable(s), see [23,25–27,41,42] for glioma interacting with tissue and e.g., [28,92]
for swimming bacteria biased by some chemoattractant;
(iii) by accounting for biochemical and/or biophysical effects translated into cell stress and forces
acting on the cells and leading to transport terms w.r.t. the velocity variable in the kinetic
PDE on the mesolevel, see [19] for the case of cancer cells responding to a ’chemotaxis force’
proportional to the gradient of a given chemoattractant concentration;
(iv) by considering turning operators where the cell reorientation depends on the interaction
with (some of) the environmental cues and using equilibrium distributions for the moment
closure, as e.g. in [19].
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While (i) and (iv) have a rather mesoscopic flavor, (ii) and (iii) refer closer to microscopic, single
cell descriptions, therefore we employed in this work a combination of the latter: (ii) led to the
macroscopic haptotaxis term, while (iii) with the description of cell stress and associated, speed-
preserving forces acting on glioma cells yielded the terms characterizing repellent pH-taxis and
mesoscopic haptotaxis. Notice that the coupling with evolving acidity and macro- and mesoscopic
tissue led to genuine taxis, unlike previous models [23, 25–27, 41, 42] where the tactic cue (e.g.,
macroscopic tissue) was only space-dependent. To our knowledge dynamics of such complexity has
not been treated in previous works, neither numerically nor from an analytical viewpoint. In [71]
were performed interesting simulations on the kinetic level for a simpler model of cells migrating
through the extracellular matrix with oriented fibers, which they degrade according to certain
rules. Our closed macro-meso description (3.35) has the advantage of a lower dimensional phase
space, thus allowing -among others- to accommodate even further possibly relevant biological
effects with a rather detailed description via (ii) and/or (iii), without facing problems due to a
prohibitive increase of the number of kinetic variables and therewith associated computational
costs.
Concerning possible relationships between (i)-(iv), it has been proved in [73] that (ii) actually
implied (iii) under certain assumptions on the subcellular dynamics for a model of bacterial
run-and-tumble swimming. In [57] such connection was investigated in a less rigorous way for a
model describing glioma pseudopalisade patterning under the influence of repellent pH-taxis and
anisotropic, but non-evolving tissue.
In order to pass from the KTAP framework to effective equations for the tumor spread we
performed here a hyperbolic as well as a parabolic upscaling, according to the underlying tissue
being directed or not. The latter is still not clarified from a biological viewpoint; the study
(via numerical simulations) performed in [57] for the mentioned model of glioma pseudopalisades
revealed that such patterns which are invariably observed on histological samples of high grade
tumors [14, 89] formed in due time when using the system obtained in the parabolic limit, while
the hyperbolic scaling led to a drift-dominated system predicting only a rapid shift of the initial
aggregate of glioma cells towards the leading tissue orientation, without pattern development.
This suggests that brain tissue might be undirected and induced us here to perform numerical
simulations only for the equations obtained by parabolic scaling.
Our model makes use of DTI data and accounts for the evolution of brain tissue, transferring
biomedical information through the directional distribution of tissue fibers. As mentioned before,
this information belongs to both micro and macro worlds and they coexist in the macroscopic
limit. In Subsection 3.1 we put in evidence the versatility of this model w.r.t. the influence of
(spatially varying) tissue anisotropy in characterizing the tumor spread, thereby also considering
the impact of hypoxia. In fact, our study of dominant advective effects suggests that pH-taxis
is the dominating drift - at least as far as this model and its parameterization are concerned.
In this work we used the approaches (ii) and (iii) to describe cell-tissue interactions and (iii)
for the response of cells to acidity. This led to the anisotropy-triggered switch between myopic
diffusion with ’meso-haptotaxis’ and the migratory behavior with the supplementary ’macro-
haptotaxis’. Instead, using (ii) for cell-acid interplay and correspondingly define the turning rate
would conduct to a hypoxia-triggered switch. Several other options of combining (ii) and/or (iii)
can be conceived as well, raising further questions about the relationship of these alternative
approaches. How appropriate a particular model is for a specific problem eventually depends on
a multitude of factors and can properly be assessed when validated with adequate patient data.
The current high costs of collecting such data still keeps a reliable validation out of reach, but
the unprecedented development of biomedical technology during the last decade gives hope of it
becoming available in the near future.
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